Neo Ivy Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortune Brands Innovations
FBIN
|
+$421K |
| 2 |
Under Armour
UAA
|
+$420K |
| 3 |
CSX Corp
CSX
|
+$419K |
| 4 |
KB Home
KBH
|
+$414K |
| 5 |
Howmet Aerospace
HWM
|
+$406K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CarMax
KMX
|
+$359K |
| 2 |
Clorox
CLX
|
+$358K |
| 3 |
Starbucks
SBUX
|
+$326K |
| 4 |
New York Times
NYT
|
+$324K |
| 5 |
HCA Healthcare
HCA
|
+$321K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.49% |
| 2 | Technology | 13.65% |
| 3 | Consumer Discretionary | 13.29% |
| 4 | Industrials | 12.35% |
| 5 | Healthcare | 9.56% |
Similar funds
Neo Ivy Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Neo Ivy Capital Management held 608 positions worth $38M, up 1.9% from $37.3M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Neo Ivy Capital Management deployed $4.97M of net new capital in Q3 2022, opening 217 new positions and adding to 85 existing holdings. Its largest new stake was Fortune Brands Innovations: 7,761 shares worth $356K.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was New York Times, an estimated $324K trimmed.
- Neo Ivy Capital Management's largest Q3 2022 buy was Fortune Brands Innovations: 7,761 shares worth $356K.
- Neo Ivy Capital Management added most to Conagra Brands in Q3 2022, an estimated $373K increase.
- Neo Ivy Capital Management's biggest Q3 2022 reduction was New York Times, cutting an estimated $324K.
- Neo Ivy Capital Management fully exited CarMax in Q3 2022, selling an estimated $359K.
- Neo Ivy Capital Management's ten largest holdings make up 9.4% of its $38M portfolio in Q3 2022.
- Neo Ivy Capital Management opened 217 new positions and closed 226 in Q3 2022.
- Neo Ivy Capital Management's portfolio value rose 1.9% quarter-over-quarter to $38M.
Based on Neo Ivy Capital Management's 13F filing for Q3 2022, filed 16 Nov 2022.